Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779246 · ClinicalTrials.gov registry record · NA
Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections
A NA study, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 1,518
- Enrollment target
NCT00779246 is a NA study that has completed, run by Christiana Care Health Services. The registered enrollment target is 1,518 participants.
The verdict
NCT00779246, a NA study, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,518 participants
- Enrollment target
Study Summary
This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).
Interventions
- DRUG Chlorhexidine gluconate
- OTHER Nasal swabs for MRSA culture
- OTHER Contact isolation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,518 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00779246
The ClinicalTrials.gov registry entry for NCT00779246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,518 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine gluconate is the first listed.
NCT00779246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00779246 about?
NCT00779246 is a clinical study titled "Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections". This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include ra...
What is the current status of trial NCT00779246?
This trial is currently completed. It is a NA study. The enrollment target is 1,518 participants. The study started on 2008-06. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00779246?
The interventions under investigation include: Chlorhexidine gluconate (DRUG), Nasal swabs for MRSA culture (OTHER), Contact isolation (OTHER).
Who is sponsoring clinical trial NCT00779246?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.